Metropolitan Life Insurance Company (MetLife)’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-197
| Closed | -$644 | – | 88 |
|
|
2024
Q1 | $644 | Buy |
197
+20
| +11% | +$65 | ﹤0.01% | 2303 |
|
|
2023
Q4 | $621 | Sell |
177
-2,381
| -93% | -$8.35K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $17.1K | Hold |
2,558
| – | – | ﹤0.01% | 1970 |
|
|
2023
Q2 | $21.5K | Buy |
+2,558
| New | +$21.5K | ﹤0.01% | 1894 |
|
|
2022
Q2 | – | Sell |
-3,570
| Closed | -$15.9K | – | 2369 |
|
|
2022
Q1 | $15.9K | Sell |
3,570
-1,791
| -33% | -$7.96K | ﹤0.01% | 2190 |
|
|
2021
Q4 | $21.4K | Sell |
5,361
-3,732
| -41% | -$14.9K | ﹤0.01% | 2751 |
|
|
2021
Q3 | $79.8K | Sell |
9,093
-5,487
| -38% | -$48.2K | ﹤0.01% | 2644 |
|
|
2021
Q2 | $165K | Buy |
+14,580
| New | +$165K | ﹤0.01% | 2287 |
|